Monte Rosa Therapeutics, Inc. (GLUE)
18.80
-0.35
(-1.83%)
USD |
NASDAQ |
May 01, 16:00
18.50
-0.30
(-1.60%)
Pre-Market: 20:00
Monte Rosa Therapeutics Shareholders Equity (Quarterly) : 233.06M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Johnson & Johnson | 81.19B |
| Agenus, Inc. | -271.11M |
| BioRestorative Therapies, Inc. | 0.3567M |
| Kyntra Bio, Inc. | -30.04M |
| Kura Oncology, Inc. | 174.14M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 448.66M |
| Total Liabilities (Quarterly) | 215.60M |
| Debt to Equity Ratio | 0.1682 |
| Current Ratio | 6.123 |
| Net Debt Paydown Yield | 0.09% |